Isofol Medical AB (publ) (FRA:5IU)

Germany flag Germany · Delayed Price · Currency is EUR
0.0531
-0.0021 (-3.80%)
At close: Dec 4, 2025
-77.26%
Market Cap 18.96M
Revenue (ttm) n/a
Net Income (ttm) -4.93M
Shares Out n/a
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 0.0531
Previous Close 0.0552
Day's Range 0.0531 - 0.0531
52-Week Range 0.0465 - 0.2220
Beta n/a
RSI 53.19
Earnings Date Feb 18, 2026

About Isofol Medical AB

Isofol Medical AB (publ) operates as a clinical stage biotech company. The company develops arfolitixorin, which is in phase Ib/II clinical trial for the treatment of metastatic colorectal cancer. Isofol Medical AB (publ) was incorporated in 2008 and is based in Gothenburg, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2008
Employees 5
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 5IU
Full Company Profile

Financial Performance

Financial numbers in SEK Financial Statements

News

There is no news available yet.